The Priority Review

Tag

Axatilimab

1 story

  1. Clinical trials

    Incyte posts results of Phase 3 axatilimab trial in chronic graft-versus-host disease

    Results for the Phase 3, open-label study of axatilimab in Japanese participants with recurrent or refractory active chronic graft-versus-host disease were first posted on ClinicalTrials.gov on October 5, 2026. The study enrolled 21 participants and completed primary data collection on August 6, 2025.